0001845313-21-000001.txt : 20210217
0001845313-21-000001.hdr.sgml : 20210217
20210216184048
ACCESSION NUMBER: 0001845313-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210216
EFFECTIVENESS DATE: 20210217
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarkana Pharma, Inc.
CENTRAL INDEX KEY: 0001845313
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-389612
FILM NUMBER: 21641737
BUSINESS ADDRESS:
STREET 1: 1000 N. WEST ST., SUITE 1200
CITY: WILMINGTON
STATE: DE
ZIP: 19801
BUSINESS PHONE: 6493324417
MAIL ADDRESS:
STREET 1: 1000 N. WEST ST., SUITE 1200
CITY: WILMINGTON
STATE: DE
ZIP: 19801
D
1
primary_doc.xml
X0708
D
LIVE
0001845313
Sarkana Pharma, Inc.
1000 N. WEST ST., SUITE 1200
WILMINGTON
DE
DELAWARE
19801
6493324417
DELAWARE
None
None
Corporation
true
2020
Caroline
Fortier
1000 N. West St., Suite 1200
Wilmington
DE
DELAWARE
19801
Executive Officer
Mark
Cipriano
1000 N. West St., Suite 1200
Wilmington
DE
DELAWARE
19801
Executive Officer
Luc
Marengere
2 Place Alexis Nihon, Suite 902
3500 Blvd de Maisonneuve West
Westmount
A8
QUEBEC, CANADA
H3Z 3C1
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-12-21
false
true
false
0
Indefinite
1579000
Indefinite
This offering was made in exchange for certain licensing rights to investor's proprietary compound, which rights were estimated to be valued at $1,579,000.
false
1
0
0
0
false
Sarkana Pharma, Inc.
Juan Felipe Velasquez
Juan Felipe Velasquez
Attorney-in-Fact for Caroline Fortier, CEO
2021-02-16